Menopause is another major area. “Many women can’t tolerate oral progesterone. If they’re on oestrogen and have a uterus, ...
This shift matters because the pharmaceutical industry carries material weight. The sector is estimated to be responsible for ...
The other new piece to MFN in its current incarnation is the direct-to-patient platform TrumpRX, and the promise that MFN ...
Top-line results from the TRIUMPH-4 trial, carried out in patients with overweight or obesity and knee osteoarthritis, raise expectations for the prospects of retatrutide, which targets GLP-1, GIP, ...
Swiss biotech AC Immune has said that its vaccine-like alpha-synuclein-targeted immunotherapy has shown promise in slowing ...
Pfizer's oral HER2 inhibitor Tukysa looks poised to find a new role as first-line maintenance therapy for HER2-positive ...
The results of the lidERA trial in patients with HR-positive, HER2-negative early breast cancer – previewed last month and ...
AI-driven customer centricity is built on a continuously learning system that interprets behaviour, identifies intent, and ...
The deal focuses on a weight-loss pill in development at YaoPharma, a GLP-1 agonist codenamed YP05002, which is currently in ...
According to researchers, medical training has reached a stage where students know more, but understand less. Although there ...
If confirmed, the safety review could herald the imposition of restrictions on the use of the antibodies by HHS, which has ...
Bristol Myers Squibb has expanded its direct-to-consumer (DTC) sales of medicines in the US with the addition of its psoriasis therapy Sotyktu. All of the DTC channels offer discounts for people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback